G-CSF protects human brain vascular endothelial cells injury induced by high glucose, free fatty acids and hypoxia through MAPK and Akt signaling

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Su, Jingjing ^a   Zhou, Houguang ^b   Tao, Yinghong ^c   Guo, Jingchun ^d   Guo, Zhuangli ^e   Zhang, Shuo ^b   Zhang, Yu ^b   Huang, Yanyan ^b   Tang, Yuping ^b   Dong, Qiang ^b   Hu, Renming ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Department of General Medicine   (China)

^d FUDAN UNIVERSITY   (China)

^e QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CASPASE 3; CELL DIVISION CYCLE PROTEIN 14A; CYCLIN B; CYCLIN E; FATTY ACID; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN PHOSPHATASE CDC14; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; MESSENGER RNA; PROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL CYCLE PROGRESSION; CELL HYPOXIA; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NEUROPROTECTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; BRAIN INJURIES; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HYPOXIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALIA;

APOPTOSIS; BLOTTING, WESTERN; BRAIN INJURIES; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYPOXIA; MITOGEN-ACTIVATED PROTEIN KINASES; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84929497376     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120707     Document Type: Article

References (51)

1. Shah QA, Tan X, Bi S, Liu X, Hu S. Differential characteristics and in vitro angiogenesis of bone marrow- and peripheral blood-derived endothelial progenitor cells: evidence from avian species. Cell Prolif. 2014; 47: 290-298. doi: 10.1111/cpr.12111 PMID: 24824967
2. de la Puente P, Muz B, Azab F, Azab AK. Cell trafficking of endothelial progenitor cells in tumor progression. Clin Cancer Res. 2013; 19: 3360-3368. doi: 10.1158/1078-0432.CCR-13-0462 PMID: 23665736
3. Fadini GP, Avogaro A. It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications. Exp Diabetes Res. 2012; 2012: 742976. doi: 10.1155/2012/742976 PMID: 22548049
4. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998; 92: 362-367. PMID: 9657732
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-967. PMID: 9020076
6. Zhan K, Bai L, Xu J. Role of vascular endothelial progenitor cells in construction of new vascular loop. Microvasc Res. 2013; 90: 1-11. doi: 10.1016/j.mvr.2013.06.010 PMID: 23851047
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553. PMID: 9686693
8. Albiero M, Avogaro A, Fadini GP. Restoring stem cell mobilization to promote vascular repair in diabetes. Vascul Pharmacol. 2013; 58: 253-258. doi: 10.1016/j.vph.2013.01.003 PMID: 23369723
9. Barthelmes D, Irhimeh MR, Gillies MC, Karimipour M, Zhou M, Zhu L, et al. Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Blood Cells Mol Dis. 2013; 51: 163-173. doi: 10.1016/j.bcmd.2013.05.002 PMID: 23714230
10. Fadini GP, Ferraro F, Quaini F, Asahara T, Madeddu P. Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. Stem Cells Transl Med. 2014; 3: 949-957. doi: 10.5966/ sctm.2014-0052 PMID: 24944206
11. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest. 2007; 117: 1249-1259. PMID: 17476357
12. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45: 1449-1457. PMID: 15862417
13. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006; 26: 2140-2146. PMID: 16857948
14. Zhou WJ, Zhu DL, Yang GY, Zhang Y, Wang HY, Ji KD, et al. Circulating endothelial progenitor cells in Chinese patients with acute stroke. Hypertens Res. 2009; 32: 306-310. doi: 10.1038/hr.2009.16 PMID: 19262489
15. Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation. 2007; 116: 163-173. PMID: 17592079
16. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002; 106: 2781-2786. PMID: 12451003
17. Mukherjee D. Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus. Best Pract Res Clin Endocrinol Metab. 2009; 23: 335-345. doi: 10.1016/j.beem.2008.10.015 PMID: 19520307
18. Béjot Y, Giroud M. Stroke in diabetic patients. Diabetes Metab. 2010; 36 Suppl 3: S84-87. doi: 10. 1016/S1262-3636(10)70472-9 PMID: 21211741
19. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991; 78: 2791-2808. PMID: 1720034
20. Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor GCSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005; 115: 2083-2098. PMID: 16007267
21. Li B, Gonzalez-Toledo ME, Piao CS, Gu A, Kelley RE, Zhao LR. Stem cell factor and granulocyte colony- stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice. Alzheimers Res Ther. 2011; 3: 8. doi: 10.1186/alzrt67 PMID: 21406112
22. Song S, Sava V, Rowe A, Li K, Cao C, Mori T, et al. Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease. Neurosci Lett. 2011; 487: 153-157. doi: 10. 1016/j.neulet.2010.10.012 PMID: 20951187
23. Lu CZ, Xiao BG. G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia. Biochem Soc Trans. 2006; 34: 1327-1333. PMID: 17073813
24. Sugiyama Y, Yagita Y, Oyama N, Terasaki Y, Omura-Matsuoka E, Sasaki T, et al. Granulocyte colonystimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke. Stroke. 2011; 42: 770-775. doi: 10.1161/STROKEAHA.110.597799 PMID: 21257824
25. Solaroglu I, Tsubokawa T, Cahill J, Zhang JH. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience. 2006; 143: 965-974. PMID: 17084035
26. Tousoulis D, Briasoulis A, Vogiatzi G, Valatsou A, Kourkouti P, Pantopoulou A, et al. Effects of direct infusion of bone marrow-derived progenitor cells and indirect mobilization of hematopoietic progenitor cells on atherosclerotic plaque and inflammatory process in atherosclerosis. Int J Cardiol. 2013; 168: 4769-4774. doi: 10.1016/j.ijcard.2013.07.229 PMID: 23958421
27. Zhou HG, Liu L, Zhang Y, Huang YY, Tao YH, Zhang S, et al. Glutathione prevents free fatty acids-induced oxidative stress and apoptosis in human brain vascular endothelial cells through Akt pathway. CNS Neurosci Ther. 2013; 19: 252-261. doi: 10.1111/cns.12068 PMID: 23521913
28. Su J, Zhou H, Tao Y, Guo Z, Zhang S, Zhang Y, et al. HCdc14A is involved in cell cycle regulation of human brain vascular endothelial cells following injury induced by high glucose, free fatty acids and hypoxia. Cell Signal. 2014; 27: 47-60. doi: 10.1016/j.cellsig.2014.10.003 PMID: 25463242
29. Chinopoulos C, Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J. 2006; 273: 433-450. PMID: 16420469
30. Li C, Hashimi SM, Good DA, Cao S, Duan W, Plummer PN, et al. Apoptosis and microRNA aberrations in cancer. Clin Exp Pharmacol Physiol. 2012; 39: 739-746. doi: 10.1111/j.1440-1681.2012.05700.x PMID: 22409455
31. Wolf G. Molecular mechanisms of renal hypertrophy: role of p27Kip1. Kidney Int. 1999; 56: 1262-1265. PMID: 10504470
32. O'Connor PM. Mammalian G1 and G2 phase checkpoints. Cancer Surv. 1997; 29: 151-182. PMID: 9338101
33. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001; 410: 37-40. PMID: 11242034
34. Su JJ, Pan H, Zhou HG, Tang YP, Dong Q, Liu JR. Acid-sensing ion channels activation and hypoxia upregulate Homer1a expression. CNS Neurosci Ther. 2014; 20: 264-274. doi: 10.1111/cns.12206 PMID: 24433527
35. Noshita N, Lewén A, Sugawara T, Chan PH. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2001; 21: 1442-1450. PMID: 11740206
36. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience. 1995; 68: 615-619. PMID: 8577361
37. Fan B, Gu JQ, Yan R, Zhang H, Feng J, Ikuyama S. High glucose, insulin and free fatty acid concentrations synergistically enhance perilipin 3 expression and lipid accumulation in macrophages. Metabolism. 2013; 62: 1168-1179. doi: 10.1016/j.metabol.2013.02.013 PMID: 23566650
38. Okazaki T, Ebihara S, Asada M, Kanda A, Sasaki H, Yamaya M. Granulocyte colony- stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int Immunol. 2006; 18: 1-9. PMID: 16352631
39. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, et al. Granulocyte colony- stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005; 25: 296-301. PMID: 15569821
40. Qiu C, Xie Q, Zhang D, Chen Q, Hu J, Xu L. GM-CSF Induces Cyclin D1 Expression and Proliferation of Endothelial Progenitor Cells via PI3K and MAPK Signaling. Cell Physiol Biochem. 2014; 33: 784-795. doi: 10.1159/000358652 PMID: 24662605
41. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ. 2006; 174: 927-933. PMID: 16517764
42. Floel A, Warnecke T, Duning T, Lating Y, Uhlenbrock J, Schneider A, et al. Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease-a randomized controlled trial. PLoS One. 2011; 6: e19767. doi: 10.1371/journal.pone.0019767 PMID: 21625426
43. Lan X, Qu H, Yao W, Zhang C. Granulocyte-colony stimulating factor inhibits neuronal apoptosis in a rat model of diabetic cerebral ischemia. Tohoku J Exp Med. 2008; 216: 117-126. PMID: 18832793
44. Sicinska E, Lee YM, Gits J, Shigematsu H, Yu Q, Rebel VI, et al. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes. Mol Cell Biol. 2006; 26: 8052-8060. PMID: 16954383
45. Ohtsuki F, Yamamoto M, Nakagawa T, Tanizawa T, Wada H. Granulocyte-macrophage colony-stimulating factor abrogates transforming growth factor-beta 1-mediated cell cycle arrest by up-regulating cyclin D2/Cdk6. Br J Haematol. 1997; 98: 520-527. PMID: 9332304
46. Kong T, Choi JK, Park H, Choi BH, Snyder BJ, Bukhari S, et al. Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte- macrophage colony-stimulating factor in rats. Laboratory investigation. J Neurosurg. 2009; 111: 155-163. doi: 10.3171/2008.12.JNS08172 PMID: 19361262
47. Li JM, Yao ZF, Zou YZ, Ge JB, Guan AL, Wu J, et al. The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice. Mol Biol Rep. 2012; 39: 5-12. doi: 10.1007/s11033-011-0703-8 PMID: 21431359
48. Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, et al. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease. Brain Res. 2008; 1194: 130-137. doi: 10.1016/j.brainres.2007.11.058 PMID: 18166168
49. Ueda K, Takano H, Hasegawa H, Niitsuma Y, Qin Y, Ohtsuka M, et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol. 2006; 26: e108-113. PMID: 16574892
50. Chen WF, Jean YH, Sung CS, Wu GJ, Huang SY, Ho JT, et al. Intrathecally injected granulocyte colony- stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways. Neuroscience. 2008; 153: 31-43. doi: 10.1016/j.neuroscience.2008. 01.062 PMID: 18358629
51. Tanguay PL, Rodier G, Meloche S. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis. Biochem J. 2010; 428: 103-111. doi: 10.1042/BJ20091604 PMID: 20236090